For UK tech startups raising seed capital, selecting the appropriate funding instrument represents one of the most consequential early decisions affecting future fundraising, founder economics, and investor relationships.
Whilst priced equity rounds provide clarity and traditional structure, convertible instruments offer speed and flexibility that often better suit early-stage uncertainty.
This comprehensive guide explores the three primary seed funding instruments used by UK startups – convertible loan notes, SAFE agreements, and priced equity – helping founders understand when each makes strategic sense, the tax implications for companies and investors, and how to negotiate optimal terms.
Convertible Loan Notes vs SAFE vs Priced Equity
Understanding the Funding Instrument Landscape
Seed funding instruments have evolved significantly over the past decade, moving from predominantly priced equity rounds towards convertible instruments that defer valuation discussions until companies have more traction and leverage.
Priced equity rounds involve selling shares at agreed valuations with immediate ownership transfer, full documentation of shareholder rights, and extensive legal process. These dominated UK seed fundraising historically but have declined in prevalence for smallest rounds.
Convertible loan notes represent loans that convert into equity at future financing rounds, typically at discounted valuations. These originated in the US but gained substantial UK adoption through the 2010s.
SAFE agreements (Simple Agreement for Future Equity) provide right to future equity without interest or repayment obligations, created by Y Combinator in 2013. UK adoption has grown significantly though legal framework remains less settled than in the US.
| Instrument Type | Legal Nature | Conversion Trigger | Documentation Complexity | Typical Cost |
|---|---|---|---|---|
| Priced Equity | Share purchase | Immediate | High | £15K-£50K+ |
| Convertible Loan Note | Debt converting to equity | Qualified financing or maturity | Moderate | £5K-£15K |
| SAFE | Equity right | Qualified financing or liquidity | Low | £2K-£8K |
The choice between instruments affects immediate and long-term economics, timeline to funding completion, complexity and legal costs, investor pool access, and future fundraising dynamics.
Discover 7 Smart Strategies To Scale Your Funded Tech Startup By Boosting Cashflow And Saving Tax
Convertible Loan Notes: Structure and Mechanics
Convertible loan notes (CLNs) represent the most established convertible instrument in UK markets, with well-understood legal framework and extensive market precedent.
How Convertible Loan Notes Work
Legal structure treats investment as debt to the company, bearing interest at specified rates (typically 0-8% annually), convertible into equity at future qualified financing rounds, with provisions for repayment if conversion doesn’t occur by maturity date.
Conversion mechanics typically specify that notes convert at qualified financing (usually defined as £500K-£2M minimum raise from institutional investors), at valuation of the qualified round subject to discount (typically 15-30%), or with valuation cap providing maximum conversion price.
Interest treatment can be structured as cash interest paid annually (rare for startups), PIK interest rolled into principal and converting with note, or no interest (increasingly common for founder-friendly terms).
Key Terms in CLN Agreements
Discount rate provides note holders with lower conversion price than new investors as reward for earlier risk. Market standard UK rates range 15-25%, with 20% representing typical compromise.
| Discount Rate | Investor Perspective | Founder Perspective | Typical Scenario |
|---|---|---|---|
| 10-15% | Modest reward | Founder-friendly | Strong company leverage |
| 20% | Market standard | Balanced | Standard terms |
| 25-30% | Significant reward | Investor-friendly | Weak company leverage |
Valuation cap sets maximum conversion price protecting investors if qualified round values company substantially higher than anticipated. For example, £5M cap on note means regardless of Series A valuation, note converts at maximum £5M pre-money valuation.
Example conversion: Investor contributes £100K via convertible note with 20% discount and £5M valuation cap. Series A raises at £10M pre-money valuation with £1.00 share price.
Without cap: £100K converts at £0.80/share (20% discount) = 125,000 shares (1.25% of post-conversion) With cap: £100K converts at £0.50/share (based on £5M cap) = 200,000 shares (2% of post-conversion)
The cap protects investors in high-growth scenarios whilst discount provides baseline benefit in all conversions.
Qualified financing definition typically requires £500K-£2M minimum raise from institutional investors to trigger conversion, preventing conversion at unfavourable small rounds whilst ensuring conversion at meaningful Series A raises.
Maturity date establishes deadline for conversion or repayment, typically 18-36 months from note issuance. Upon maturity without qualified financing, notes either convert at pre-agreed valuation, extend maturity by mutual agreement, or require repayment (though repayment rarely practical for cash-constrained startups).
Tax Implications of Convertible Loan Notes
For companies, convertible loan notes create deductible interest expense (if interest is charged) reducing corporation tax, though interest paid to individuals may require 20% withholding tax. Conversion itself doesn’t trigger corporate tax charges.
For investors, interest received faces income tax at marginal rates (20-45%), though many notes structure zero or PIK interest avoiding this. Upon conversion, the loan principal becomes share acquisition cost for capital gains purposes.
SEIS/EIS interaction with convertible notes requires careful structuring. Notes themselves don’t qualify for SEIS/EIS relief (as they’re debt not equity), but conversion can qualify if structured properly. Investors should ensure advance assurance obtained for equity that notes will convert into.
Note holder rights during loan period typically don’t include board representation or information rights, though sophisticated investors negotiate for these despite debt structure.
SAFE Agreements: The Founder-Friendly Alternative
SAFE agreements emerged from Silicon Valley addressing convertible note complexities whilst providing even simpler, faster fundraising mechanics.
UK adoption has grown substantially despite some legal uncertainty compared to US framework.
SAFE Structure and Differences from Convertible Notes
Legal nature of SAFEs represents right to future equity rather than debt, creating no interest obligations, no maturity date requiring repayment, and no formal debt on balance sheet (though accounting treatment varies).
Conversion triggers typically include equity financing rounds of specified minimums, liquidity events (acquisition, IPO), or dissolution/winding up of company.
Key advantages vs convertible notes include simpler legal documentation reducing transaction costs, no interest calculations or obligations, no maturity date creating repayment pressure, and cleaner balance sheet treatment.
| Feature | Convertible Loan Note | SAFE |
|---|---|---|
| Interest | Usually charged (0–8%) | None |
| Maturity Date | Yes (typically 18–36 months) | No |
| Legal Nature | Debt | Equity right |
| Balance Sheet | Liability | May be equity or note disclosed |
| Investor Rights | Limited until conversion | None until conversion |
Disadvantages of SAFEs include less established UK legal framework creating some uncertainty, no investor leverage from maturity date potentially allowing indefinite deferral, and some investor concerns about lack of downside protection from maturity provisions.
SAFE Valuation Cap and Discount Mechanics
Post-money vs pre-money SAFEs represent critical distinction affecting founder dilution calculations.
Pre-money SAFEs (original Y Combinator standard) calculate conversion based on pre-money valuation of subsequent round, leading to dilution calculations that can surprise founders when multiple SAFEs are outstanding.
Post-money SAFEs (Y Combinator updated standard from 2018) specify exact percentage ownership SAFE holders will receive upon conversion, providing founders with certainty about dilution regardless of total SAFE amounts raised.
Example comparison: Company raises £500K via SAFEs with £5M valuation cap, then raises Series A at £10M pre-money.
Pre-money SAFE: £500K converts at £5M valuation = 10% (before Series A investment) After Series A investment: Dilution depends on Series A amount and other conversions
Post-money SAFE: £500K converts at £5M post-money = exactly 10% (after all conversions) Clear dilution calculation: Founders know precisely what they’ll own post-conversion
UK market practice increasingly favours post-money SAFEs for founder clarity, though investors sometimes prefer pre-money SAFEs in multiple SAFE scenarios.
Tax Treatment of SAFEs
UK tax treatment of SAFEs remains somewhat uncertain given their recent introduction and hybrid nature between debt and equity.
HMRC’s position hasn’t provided definitive guidance, creating some uncertainty. Most tax advisers treat SAFEs similarly to convertible notes, with principal converting to share acquisition cost and no interest element creating income tax.
SEIS/EIS qualification for SAFE conversions requires careful structuring and advanced assurance from HMRC. The converted equity should qualify if the underlying company qualifies, but advance assurance provides certainty.
Accounting treatment varies with FRS 102 and FRS 105, providing different approaches. Some companies treat SAFEs as embedded derivatives, others as equity instruments. Professional accounting advice essential for proper treatment.
Tax Treatment of SAFEs
Priced Equity Rounds: When Traditional Structure Makes Sense
Despite the rise of convertible instruments, priced equity rounds remain appropriate and advantageous in many scenarios, particularly as companies mature and investor sophistication increases.
Structure of Priced Equity Rounds
Share subscription agreements document investors purchasing shares at an agreed price per share, creating immediate ownership with voting rights, information rights, and board representation where negotiated.
Valuation clarity provides all stakeholders with an unambiguous company valuation, eliminating conversion uncertainties and creating a clean cap table without future conversion complications.
Full documentation typically includes a subscription agreement, shareholders’ agreement establishing investor rights and protections, amended articles of association, and disclosure letter identifying company representations.
When Priced Equity Makes Sense
Larger rounds exceeding £1M-£2M increasingly justify priced equity’s additional complexity and cost, as institutional investors prefer clear equity ownership and sophisticated investors demand comprehensive rights.
Investor requirements, particularly from VCs or institutional angels, often necessitate priced equity with full shareholder agreements establishing board seats, information rights, anti-dilution protection, and drag-along rights.
Mature business models with clear traction and revenue reduce valuation uncertainty, making priced rounds more feasible without extensive negotiations over valuations and projections.
| Company Stage | Typical Instrument | Rationale |
|---|---|---|
| Pre-product | SAFE | Maximum speed, minimal valuation certainty |
| Early traction | Convertible note | Balance of speed and investor protection |
| Clear revenue | Priced equity | Valuation supportable, investor sophistication |
| Series A | Priced equity | Standard institutional investment structure |
Exit considerations mean some acquirers prefer clean cap tables without outstanding convertible instruments, though this rarely drives primary decision-making.
Advantages and Disadvantages
Advantages of priced equity include immediate ownership clarity for all shareholders, comprehensive investor rights and protections through shareholders’ agreements, a clean cap table without conversion complications, and a well-established UK legal framework.
Disadvantages encompass extended negotiation periods over valuations and terms (typically 6-12 weeks vs 2-4 weeks for convertibles), higher legal costs (£15K-£50K vs £5K-£15K), potential valuation disagreements delaying or preventing rounds, and a fixed valuation that may prove unfavourable if traction accelerates before close.
Choosing the Right Instrument: Decision Framework
Selecting optimal funding instruments requires assessing multiple factors specific to company circumstances, investor preferences, and strategic objectives.
Company Stage and Traction Assessment
Pre-revenue companies with limited traction typically benefit from convertible instruments deferring valuation discussions until meaningful metrics exist, reducing negotiation friction and accelerating funding completion.
Revenue-generating companies with clear traction can justify valuations more easily, making priced equity feasible without excessive negotiation whilst providing investors with clearer ownership understanding.
Round size correlation suggests convertibles optimal for rounds under £500K, mixed approaches for £500K-£1M, and priced equity increasingly standard above £1M particularly with institutional investors.
Investor Sophistication and Preferences
Angel investors typically accept convertible instruments readily, valuing speed and simplicity over extensive rights and protections. Experienced angel syndicates may have house preferences for specific instruments.
Venture capital firms predominantly require priced equity for meaningful investments, seeking board representation and comprehensive shareholder rights through formal shareholders’ agreements.
Strategic investors from corporates may have varying preferences depending on investment objectives and internal processes, with some accepting convertibles whilst others require full equity documentation.
Speed and Cost Considerations
Timeline pressure favouring convertibles when companies need rapid funding completion (4-6 weeks vs 8-12 weeks for priced equity), when runway concerns make speed critical, or when market windows require fast execution.
Cost optimisation through convertibles reducing legal spend by 50-70% (£5K-£15K vs £15K-£50K) and minimising management distraction during documentation processes.
Future round implications mean multiple convertible raises can create complex cap table calculations and dilution uncertainties potentially complicating Series A, though these rarely prove insurmountable.
Negotiating Convertible Instrument Terms
Whether selecting convertible notes or SAFEs, specific terms significantly impact founder economics and future fundraising dynamics requiring careful negotiation.
Discount Rate Negotiations
Market benchmarking for UK seed rounds typically shows 15-25% discounts with 20% representing market standard. Stronger company leverage drives toward 15%, whilst investor leverage pushes toward 25-30%.
Multiple convertibles with different discount rates can reward earlier investors with higher discounts (e.g., first £250K at 25%, next £250K at 20%) or maintain consistent rates across entire round.
Valuation Cap Setting
Cap calibration requires balancing investor protection against founder economics. Conservative founders set caps at 2-3x current implied valuation, whilst aggressive approaches use 4-5x multiples.
Example scenarios: Company raising £500K via convertible note estimates current value £2M-£3M.
Conservative cap: £6M (2-3x current) provides meaningful investor protection Moderate cap: £8M-£10M balances protection with founder economics
Aggressive cap: £12M-£15M (4-5x current) favours founders but may deter investors
No cap structures exist but typically require correspondingly higher discount rates (30-40%) providing investor protection through discount rather than cap.
Qualified Financing Definitions
Threshold amounts typically range £500K-£2M defining minimum raise triggering conversion. Lower thresholds (£500K) favour investors through earlier conversion certainty, whilst higher thresholds (£1.5M-£2M) favour founders by preventing conversion at small bridge rounds.
Investor quality requirements sometimes specify qualified financing must include institutional or professional investors, preventing conversion triggered by unsophisticated investors at potentially unfavourable terms.
Pro-Rata Rights and Other Terms
Pro-rata participation rights allow convertible instrument holders to participate in future rounds maintaining ownership percentages. These increasingly common provisions provide investors with valuable rights protecting against dilution.
Information rights during note/SAFE period sometimes negotiated by sophisticated investors seeking monthly financial updates, board observer status, or annual audited accounts despite lack of formal equity ownership.
Most Favoured Nation (MFN) clauses ensure if subsequent convertible investors receive better terms, earlier investors automatically receive equivalent treatment. These protect early investors whilst creating administrative complexity tracking multiple instrument terms.
Tax Planning Considerations Across Instruments
Different funding instruments create varying tax implications for companies and investors requiring strategic consideration during instrument selection and structuring.
Corporation Tax Implications
Convertible loan notes with interest create deductible interest expense reducing corporation tax, though 20% withholding tax may apply to interest paid to individuals (not companies). Companies should model whether interest deductibility benefits justify withholding tax complexity.
SAFEs create no interest deductions given their equity-like nature, simplifying corporation tax compliance whilst eliminating potential deductibility benefits.
Priced equity provides no immediate tax deductions but establishes clear share capital structure affecting future distributions, buybacks, and reorganisations.
Personal Tax for Founders and Investors
Founders face minimal immediate tax implications from any instrument, though convertible instruments defer share ownership and associated tax positions until conversion.
Investors receiving interest from convertible notes face income tax at marginal rates (20-45%), encouraging many notes to structure zero or PIK interest. Upon conversion or share acquisition, cost basis for capital gains purposes established for future disposals.
SEIS/EIS planning requires ensuring convertible instruments structure conversions qualifying for relief. Advance assurance from HMRC provides certainty, typically requiring application before fundraising with conversion terms clearly specified.
Employee Share Schemes and Convertible Instruments
EMI option grants during convertible instrument periods use company valuations that may differ from eventual conversion valuations, potentially creating favourable option exercise prices if carefully timed.
409A-style valuations (for US tax purposes if US employees hold options) must account for convertible instruments in company valuation, potentially creating complexity in waterfall calculations.
Common Mistakes and How to Avoid Them
Understanding typical errors in convertible instrument selection and structuring helps founders avoid costly pitfalls.
Raising excessive amounts on convertibles creates complex cap table mathematics with multiple conversion prices, potentially deterring Series A investors. Limiting convertible raises to £500K-£1M before moving to priced equity maintains simplicity.
Poorly defined qualified financing thresholds with overly low amounts (e.g., £250K) risk unwanted conversion at small bridge rounds, whilst excessively high thresholds (e.g., £5M) may prevent conversion at legitimate Series A raises.
Neglecting SEIS/EIS advance assurance for convertible instruments creates investor uncertainty about tax relief availability, potentially reducing amounts raised or valuations achieved.
Inconsistent terms across convertibles, where different investors negotiate varying discounts, caps, or rights create administrative complexity and potential investor relationship issues when terms become known.
Ignoring accounting implications of instrument choice affects financial statement presentation potentially impacting investor perceptions, bank covenant compliance, or future fundraising optics.
International Considerations
UK companies raising from international investors face additional complexity ensuring instrument structures work across jurisdictions.
US Investor Considerations
US tax treatment of UK convertible instruments requires analysis under US tax rules which may differ from UK treatment. US investors should consult US tax advisers about specific implications.
SAFE familiarity among US investors may create preferences for SAFEs over convertible notes given US market dominance of SAFE structures and extensive US legal precedent.
Withholding tax obligations on interest paid to US investors require analysis under UK-US tax treaty, potentially requiring reduced withholding through treaty relief procedures.
EU Investor Considerations
Withholding tax variations across EU jurisdictions affect interest payments to EU investors, requiring country-by-country analysis of applicable rates and treaty relief availability.
Legal framework recognition of novel instruments like SAFEs varies across EU countries, with some jurisdictions having less developed frameworks than the UK, creating potential legal uncertainties.
Discover 7 Smart Strategies To Scale Your Funded Tech Startup By Boosting Cashflow And Saving Tax
Conclusion: Strategic Instrument Selection
Selecting the right seed funding instrument requires balancing multiple considerations, including company stage and traction, investor sophistication and preferences, speed and cost requirements, and tax implications for all stakeholders.
The most successful UK tech startups approaching seed fundraising share common characteristics: understanding the implications of each instrument option, selecting instruments appropriate to company circumstances rather than following trends blindly, negotiating terms thoughtfully, balancing investor protection against founder economics, and ensuring proper legal and tax advice guides structuring decisions.
Poor instrument selection creates substantial complications, including complex cap table mathematics deterring future investors, unfavourable economics from poorly negotiated terms, tax inefficiencies from improper structuring, and relationship issues from inconsistent treatment of different investors.
As a general framework, consider SAFEs for speed rounds under £300K with minimal investor sophistication requirements, convertible notes for £300K-£1M balancing speed with investor protection, and priced equity for rounds above £1M, particularly with institutional investors requiring comprehensive rights.
The investment in professional advice (typically £5K-£15K for convertibles, £15K-£50K for priced equity) proves worthwhile through optimised structures, avoided mistakes, and enhanced investor confidence. For founders building substantial businesses, proper funding instrument selection and structuring provide the foundation for efficient future fundraising and optimal long-term economics.
This blog post is intended as general guidance only and does not constitute legal, tax, or investment advice. Funding instrument selection involves complex legal and tax implications that are highly fact-specific. You should always consult with qualified legal and tax advisers before implementing funding structures.
FAQ
Q1. What is a convertible loan note?
A1. It is a loan that converts into shares later, usually with a discount or valuation cap.
Q2. What is a SAFE agreement?
A2. It gives investors the right to future equity without interest or repayment.
Q3. What is priced equity?
A3. Investors buy shares immediately at a fixed company valuation.
Q4. Which option is fastest and cheapest?
A4. SAFEs are usually the fastest and lowest-cost option.
Q5. When should startups use priced equity?
A5. When raising larger funds with clear valuation and institutional investors.
Meet Serkan
Serkan is the Co-Partner of M.Tatar & Associates, a chartered accountancy, tax advisory, and statutory auditor practice in North London. He specialises in helping tech start-up founders and CEOs make informed financial decisions, with a sustainably focused agenda and expertise in all things investment property. He regularly shares his knowledge and best advice on his blog and other channels, such as LinkedIn. Book a call today to learn more about what Serkan and M.Tatar & Associates can do for you.